SB 480 Hawaii Senate · 2025 Regular Session

RELATING TO HEALTH.

Summary
Prohibits drug manufacturers and wholesale distributors from restricting or denying access for pharmacies contracted with 340B covered entities to purchase 340B drugs at a discounted price under the federal 340B Drug Pricing Program. Imposes civil penalties for engaging in unfair or deceptive acts or practices in the conduct of any trade or commerce.
Bill status in committee 1 of 4 stages cleared
Introduction
Jan 2025
Committee Review
Floor Vote
Governor
Introduced Jan 17, 2025 Last action Feb 10, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
5
Key actions
1
Committee
2
Feb 4, 2025
Upper · Passed
The committee(s) on HHS has scheduled a public hearing on 02-10-25 1:20PM; Conference Room 225 & Videoconference.
upper
Jan 21, 2025
Committee
Referred to HHS, CPN/JDC.
upper
Jan 17, 2025
Introduced
Introduced.
upper
1 primary · 1 co-sponsor

Sponsors